Correlation Between Johnson Johnson and Pacira BioSciences,
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Pacira BioSciences,, you can compare the effects of market volatilities on Johnson Johnson and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Pacira BioSciences,.
Diversification Opportunities for Johnson Johnson and Pacira BioSciences,
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Johnson and Pacira is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Pacira BioSciences, go up and down completely randomly.
Pair Corralation between Johnson Johnson and Pacira BioSciences,
Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Pacira BioSciences,. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 3.06 times less risky than Pacira BioSciences,. The stock trades about -0.11 of its potential returns per unit of risk. The Pacira BioSciences, is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 1,556 in Pacira BioSciences, on August 30, 2024 and sell it today you would earn a total of 108.00 from holding Pacira BioSciences, or generate 6.94% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Johnson Johnson vs. Pacira BioSciences,
Performance |
Timeline |
Johnson Johnson |
Pacira BioSciences, |
Johnson Johnson and Pacira BioSciences, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and Pacira BioSciences,
The main advantage of trading using opposite Johnson Johnson and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.Johnson Johnson vs. Emergent Biosolutions | Johnson Johnson vs. Bausch Health Companies | Johnson Johnson vs. Neurocrine Biosciences | Johnson Johnson vs. Teva Pharma Industries |
Pacira BioSciences, vs. Emergent Biosolutions | Pacira BioSciences, vs. Bausch Health Companies | Pacira BioSciences, vs. Neurocrine Biosciences | Pacira BioSciences, vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |